Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-04-20 00:00:00 ET · period of report 2022-04-18 · accession 0001567619-22-008742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-20 | 2022-04-18 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $81.91 | -20.0K | 335.0K | -6% | -$1.64M |
| D | 2022-04-20 | 2022-04-18 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +20.0K | 355.0K | +6% | +$749.2K |
| D | 2022-04-20 | 2022-04-18 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -20.0K | 55.0K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | S | D | 20,000 | $81.91 | 334,983 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 60% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. |
| 2 | Common | Common Stock | 2022-04-18 | M | A | 20,000 | $37.46 | 354,983 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 60% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2022-04-18 | M | D | 20,000 | $0.00 | 55,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 20,000 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on December 9, 2021, as amended on March 11, 2022. Mr. Bienaime's former spouse will receive approximately 60% of the net proceeds from the shares sold in this transaction pursuant to a marital separation agreement between her and Mr. Bienaime. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |